BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10447529)

  • 21. Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism.
    Vahl T; D'Alessio D
    Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):461-8. PubMed ID: 12806222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of GLP-1 in meal-taking.
    Hellström PM; Näslund E
    Appetite; 1999 Apr; 32(2):276. PubMed ID: 10097034
    [No Abstract]   [Full Text] [Related]  

  • 23. [GIP and GLP-1: multiplicity of regulator mechanisms for insulin secretion].
    Thorens B
    Journ Annu Diabetol Hotel Dieu; 2004; ():111-25. PubMed ID: 15259310
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiac metabolism as a target for the treatment of heart failure.
    Taegtmeyer H
    Circulation; 2004 Aug; 110(8):894-6. PubMed ID: 15326079
    [No Abstract]   [Full Text] [Related]  

  • 25. GLP-1 in NIDDM.
    Holst JJ
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S156-60. PubMed ID: 8894501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Miniglucagon: is the precursor a traitor to its family or a genius? ].
    Bataille D; Fontés G; Costes S; Longuet C; Dalle S
    Journ Annu Diabetol Hotel Dieu; 2004; ():139-49. PubMed ID: 15259312
    [No Abstract]   [Full Text] [Related]  

  • 27. Discussing the role of glucagonlike peptide-I.
    Holst JJ; Orskov C
    Diabetes Care; 1992 Oct; 15(10):1440-1. PubMed ID: 1425120
    [No Abstract]   [Full Text] [Related]  

  • 28. Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potential.
    Holst JJ
    Curr Med Chem; 1999 Nov; 6(11):1005-17. PubMed ID: 10519910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gluco-incretin hormones in insulin secretion and diabetes].
    Thorens B
    Med Sci (Paris); 2003; 19(8-9):860-3. PubMed ID: 14593618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Review: regulation of glucose metabolism].
    Yamada Y; Seino Y
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():153-8. PubMed ID: 12238041
    [No Abstract]   [Full Text] [Related]  

  • 31. [Digestive tract hormones and pancreatic secretion].
    Shima K
    Nihon Naibunpi Gakkai Zasshi; 1990 Dec; 66(12):1228-35. PubMed ID: 2292313
    [No Abstract]   [Full Text] [Related]  

  • 32. [Glucagon-like peptide-1 (GLP-1) receptor].
    Taminato T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():535-41. PubMed ID: 12238094
    [No Abstract]   [Full Text] [Related]  

  • 33. Hormone-sensitive lipase has a role in lipid signaling for insulin secretion but is nonessential for the incretin action of glucagon-like peptide 1.
    Peyot ML; Nolan CJ; Soni K; Joly E; Lussier R; Corkey BE; Wang SP; Mitchell GA; Prentki M
    Diabetes; 2004 Jul; 53(7):1733-42. PubMed ID: 15220197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity of serum insulin concentrations to glucagon-like peptide 1 (7-36)amide in sheep.
    Faulkner A
    Biochem Soc Trans; 1991 Aug; 19(3):311S. PubMed ID: 1783147
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro insulinomimetic [corrected] effects of GLP-1 in liver, muscle and fat.
    Valverde I; Villanueva-Peñacarrillo ML
    Acta Physiol Scand; 1996 Jul; 157(3):359-60. PubMed ID: 8830894
    [No Abstract]   [Full Text] [Related]  

  • 36. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39.
    Edwards CM; Todd JF; Mahmoudi M; Wang Z; Wang RM; Ghatei MA; Bloom SR
    Diabetes; 1999 Jan; 48(1):86-93. PubMed ID: 9892226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects.
    Kjems LL; Holst JJ; Vølund A; Madsbad S
    Diabetes; 2003 Feb; 52(2):380-6. PubMed ID: 12540611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both involved in regulating the metabolic stability of glucagon-like peptide-1 in vivo.
    Plamboeck A; Holst JJ; Carr RD; Deacon CF
    Adv Exp Med Biol; 2003; 524():303-12. PubMed ID: 12675252
    [No Abstract]   [Full Text] [Related]  

  • 39. Pancreatic and extrapancreatic effects of GLP-1.
    Valverde I; Villanueva-Peñacarrillo ML; Malaisse WJ
    Diabetes Metab; 2002 Dec; 28(6 Pt 2):3S85-9; discussion 3S108-12. PubMed ID: 12688638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GLP-1 and GLP-1(7-36) amide: influences on basal and stimulated insulin and glucagon secretion in the mouse.
    Fridolf T; Böttcher G; Sundler F; Ahrén B
    Pancreas; 1991 Mar; 6(2):208-15. PubMed ID: 1886889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.